Anebulo Pharmaceuticals, Inc.

NasdaqCM:ANEB Stock Report

Market Cap: US$37.9m

Anebulo Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ANEB?
Owner TypeNumber of SharesOwnership Percentage
General Public1,934,5897.46%
Institutions1,977,8107.63%
Hedge Funds5,366,29020.7%
Individual Insiders16,654,52864.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 16 shareholders own 92.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
46.3%
Joseph Lawler
12,000,000US$17.5m0%no data
20.7%
22NW, LP
5,366,290US$7.8m0%5.37%
18%
Aron English
4,654,528US$6.8m0%no data
2.47%
LVW Advisors, LLC
641,039US$935.9k-0.16%0.12%
1.97%
Nantahala Capital Management, LLC
511,073US$746.2k0%0.06%
1.54%
Morgan Stanley, Investment Banking and Brokerage Investments
399,219US$582.9k0%no data
0.61%
Ikarian Capital, LLC
157,862US$230.5k0%0.07%
0.59%
The Vanguard Group, Inc.
154,036US$224.9k0.11%no data
0.34%
Geode Capital Management, LLC
87,790US$128.2k71.1%no data
0.073%
Boothbay Fund Management, LLC
18,978US$27.7k0%no data
0.015%
BlackRock, Inc.
3,905US$5.7k3.83%no data
0.01%
Tower Research Capital Europe Limited
2,694US$3.9k-18.4%no data
0.0029%
UBS Asset Management AG
763US$1.1k0%no data
0.0014%
Lord, Abbett & Co. LLC
366US$533.90%no data
0.00029%
Bank of America Corporation, Asset Management Arm
76US$109.816.9%no data
0.00003%
JPMorgan Chase & Co, Brokerage and Securities Investments
9US$11.4-10%no data